Quoin Pharmaceuticals, Ltd. reports

Company location
Kfar Saba
Quoin Pharmaceuticals, Ltd. has filed 552 SEC EDGAR filings since 08 Apr 2016

SEC filing history

Showing 276-300 of 552 matching filings.

Per page
25
Current page
12
6-K File 001-37846

FORM 6-K

Filing date
28 Apr 2022
Reporting date
28 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-264305

424B3

Filing date
26 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-264305

EFFECT filing

Filing date
22 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
22 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
21 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37846

FORM 6-K

Filing date
13 Apr 2022
Reporting date
13 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37846

FORM 6-K

Filing date
28 Mar 2022
Reporting date
28 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89873

QUOIN PHARMACEUTICALS, LTD.

Filing date
10 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37846

FORM 6-K

Filing date
08 Mar 2022
Reporting date
08 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89873

AMENDED SC 13G

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89873

QUOIN PHARMACEUTICALS LTD.

Filing date
10 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37846

FORM 6-K

Filing date
08 Feb 2022
Reporting date
07 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37846

FORM 6-K

Filing date
31 Jan 2022
Reporting date
31 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37846

FORM 6-K

Filing date
12 Jan 2022
Reporting date
11 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37846

FORM 6-K

Filing date
20 Dec 2021
Reporting date
17 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37846

FORM 6-K

Filing date
23 Nov 2021
Reporting date
23 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89873

SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP

Filing date
12 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37846

REPORT OF FOREIGN PRIVATE ISSUER

Filing date
29 Oct 2021
Reporting date
28 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37846

REPORT OF FOREIGN PRIVATE ISSUER

Filing date
15 Oct 2021
Reporting date
15 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37846

REPORT OF FOREIGN PRIVATE ISSUER

Filing date
27 Sep 2021
Reporting date
27 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37846

REPORT OF FOREIGN PRIVATE ISSUER

Filing date
20 Sep 2021
Reporting date
20 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37846

REPORT OF FOREIGN PRIVATE ISSUER

Filing date
17 Sep 2021
Reporting date
17 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37846

REPORT OF FOREIGN PRIVATE ISSUER

Filing date
10 Sep 2021
Reporting date
10 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .